Latest update:
Thursday, March 2, 2017 - 18:21
Тhe European Commission (EC) and the US Food and Drug Administration have reached an agreement which will enable EU and FDA to avoid the duplication of inspections of medicines manufacturing facilities in the two regions.
The EU Member States' authorities will recognise inspections made by US authorities, and vice versa.
for more information:
Use of cookies
We would like to use cookies to better understand your use of this website. This helps us improve your future experience when visiting our website. If you continue your visit on our website, we shall assume that you agree with the cookies used. Detailed information on the use of cookies on this website and how to manage or withdraw your consent at any time, can be found in our